
As Medicare negotiation, PBM reform, and cash-pay channels converge, winning on auditable net value matters more than cutting list prices.
HBA Woman of the Year
over 16 years ago
Q&A: Geno Germanoover 16 years ago
Woman of the Year: Deirdre Connellyover 16 years ago
Managing the Three Drivers of Risk in Drug Developmentover 16 years ago
How to Save Your Drug Companyover 16 years ago
Science to the Rescueover 16 years ago
Twice as Nice





